The contribution to systemic lupus erythematosus (SLE) of three lupus-associated polymorphisms (involving the C4A2 complement component, Humhv3005 and the T cell antigen receptor alpha chain gene) are investigated in 81 individuals from 14 multiplex SLE families, 41 unrelated lupus patients, and 88 unrelated healthy controls. The results show a strong association between C4A deletion and SLE in these families. While the current study confirms the previously reported association between hv3005 deletion and sporadic SLE, the study fails to support this association in familial SLE patients. Moreover, no correlation is detected between the occurrence of hv3005 deletion and C4A null alleles in lupus patients, suggesting that the effects of these genetic polymorphisms on predisposition to lupus are independent. The previously reported lupus-associated T cell receptor (TCR) a chain polymorphism is not detected in any of the individuals studied here. The combined data suggest that C4A null alleles predispose strongly to development of lupus, whereas the influence of hv3005 deletion is relatively weak. The results also suggest that contributions of weak susceptibility genes such as hv3005 to disease predisposition may be obscured by the effects of stronger genetic factors and thus need to be examined in patients lacking these factors. (J. Clin. Invest. 1995Invest. . 95:1766Invest. -1772
Introduction
Systemic lupus erythematosus (SLE) is associated with formation of multiple autoantibodies and recurrent inflammation of various organ systems (1) . While the cause of SLE is not known, epidemiologic and genetic data suggest that expression of this disease reflects an interplay between genetic and environmental factors. As aberrant immune function represents the most characteristic phenotypic abnormality in lupus patients, logical candidate susceptibility genes for this condition are those encoding molecules important to normal immunity. Among these, the major histocompatibility complex (MHC)' class H genes have been particularly well studied in relation to lupus and, at least in Caucasians, associations of this disease with HLA-DR3 and to a lesser extent, DR2 have been reported (2) . However, these MHC disease associations are not apparent in all populations studied and vary among different subsets of lupus patients. Thus the class II alleles do not entirely account for genetic predisposition to lupus and the existence of other lupus-susceptibility genes appears likely.
In recent years, genetic studies of lupus patients have revealed several additional candidate genes for SLE. These include, for example, the genes encoding two early complement components, C2 and C4 (2, 3) . In one reported study, -40% of persons with complete deficiency of the second complement component (i.e., homozygous deletion of the C2 gene) had SLE; and -44% of SLE patients lacked at least one copy of their C4A complement gene, in contrast to 13% of the normal population (3) . The complement deficiencies may predispose to SLE by impairing immune complex clearance, or increasing risk of exposure to a triggering agent. Along similar lines, specific Ig and T cell antigen receptor (TCR) genotypes have also been recently invoked as possible lupus susceptibility genes. For example, one group reported an association of lupus with a restriction fragment length polymorphism (RFLP) at the T cell antigen receptor (TCR) alpha chain constant (Ca) region (4).
Previously, we described an Ig heavy chain variable region (Vh) gene polymorphism involving the closely related Vh3 germline genes, Humhv3005 and 1.9111. Our data revealed the association of lupus with the complete absence of a 9.4-kb RFLP band detected with an hv3005 gene probe (5) . Sequence analysis of the hv3005 and related Vh3 genes in individuals with various hv3005-RFLP patterns revealed the absence of hv3005 and/or hv3005-like genes in 8/9 individuals with the 9.4-kb deletions; by contrast, 1.9111 and/or 1.9111-like genes were present in these individuals (6) . Taken together, the data 1. Abbreviations used in this paper: C4A, the A isotype of the 4th component of the complement system; TCR, T cell antigen receptor; V gene, variable region gene.
suggest an increased frequency of hv3005-like gene deletion among lupus patients compared with healthy controls (5, 6) .
These observations are consistent with the contention that multiple genes are involved in the susceptibility to lupus. However, it is not clear how these genes interact with one another and, in particular, whether their effects on lupus predisposition are independent, additive and/or equal. To address these issues we investigated 14 multicase lupus families as well as unrelated lupus patients with respect to three loci implicated in susceptibility to SLE: the C4A, hv3005 and TCR Ca loci. We find that gender and C4A deletion play an important role in expression of SLE, while the influence of hv3005 deletion is weak. As TCR Ca polymorphisms are not detected in this group, the contribution of this gene to susceptibility could not be addressed. Our findings suggest that the effects of a weak susceptibility factor, such as the hv3005 deletion, on disease predisposition may become more obvious in the absence of strong disease susceptibility factors. These results emphasize the complexity inherent to identifying the genetic basis of lupus and the importance of addressing this issue in the context of both familial and sporadic cases.
Methods
Patients and nonnal donors. The study group included 41 unrelated Caucasian lupus patients and 88 healthy unrelated Caucasian controls. Fourteen multicase SLE families (at least two members affected) including 48 unaffected and 33 affected individuals were also studied. The subjects were ascertained in Toronto, Canada and four U. S. cities. All SLE patients fulfilled the American College of Rheumatology revised criteria for SLE (7) .
Genomic DNA and southern blot analyses. Genomic DNA was extracted from peripheral blood leukocytes, and was digested with the indicated restriction enzymes. The lysates were loaded into wells of a 0.7% agarose gel. After electrophoresis and transfer of DNA to nitrocellulose, the blots were hybridized with the indicated probes. Hybridization was done in 5X SSC (lx SSC = 0. 15 (8) . The TCR probes were amplified by polymerase chain reaction (PCR) from the genomic DNA of the Y79 retinoblastoma (9) , using the 5' TCR-a-ClUls primer (5'-ATATC-CAGAA-CCCTG-ACCCT-3') and the 3' TCR-a-ClDlc primer (5'-TGGGG-AAGAA-GGTGT-CT1CT-3') for TCR Cal, and the 5' C2Uls (5'-GTTCC-TGTGA-TGTCA-AGCTG-3') primer and the 3' C2Dlc (5 '-AAGGA-ATACA-GAGGC-CTAGG-3') primer for Ca2. A PstI site was added to the 5' end of each primer. The amplified DNA was cloned into pUC19 and sequenced to verify that both amplified DNA fragments were 100% identical to the reported human TCR Ca sequences (8 (6) . Accordingly, we amplified and sequenced hv3005-and 1.9H1-like genes from 13 of 18 subjects who lacked the 9.4-kb band (Table I ). The results showed that all 13 individuals had 1.911-like genes, but not the hv3005-like genes (data not shown). These data indicate that most individuals lacking the 9.4-kb restriction fragments have a complete deletion of the hv3005-like genes, including at least the hv3005 and 3d216 (or 56P1) Vh3 germline genes (12) .
Gender has long been recognized as a potentially key factor in the development of SLE, with 90% of SLE patients being female (13) . Therefore, the results of hv3005 genotype studies were analyzed by considering female and male individuals separately. There were no male SLE patients in the 14 families. Among female patients and unaffected relatives, the frequencies of the 9.4-kb deletion were 8/33 (24%) and 5/25 (20%), respectively. Therefore, even when gender was taken into consideration, these studies failed to show an association between hv3005 deletion and lupus among familial SLE patients. Previously, we studied 22 unrelated SLE patients and 42 unrelated normals, and found the 9.4-kb band to be absent in 6 patients (27%) and 2 normals (5%), yielding a P value of 0.03 (5) . As the familial data contrasted with previous observation in non-familial SLE patients, we performed further studies of hv3005 genotypes in unrelated patients and normal controls. To respectively, the C4B, the C4A and a C4A-C4B hybrid genes (due to a deletion of most of the C4A gene); + and -denote, respectively, presence and absence. In the column of "C4A gene," -1 and -2 denote, respectively, the deletion of 1 and 2 copies of the C4A gene. ND indicates not determined. lies, as well as unrelated patients and normal controls, for expression of three previously reported disease-associated RFLPs.
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Results of the analysis of hv3005/Pl polymorphisms in 41 unrelated patients and 88 healthy controls revealed a significant association between the disease and the complete deletion of the 9.4-kb band (P = 0.02). However, the current study failed to detect an association between disease and hv3005 deletion in the SLE patients from the 14 multicase families. In contrast, analyses of the same set of families revealed a significant association of C4A deletion with SLE among the female patients (56 vs. 24% for healthy female relatives; P = 0.03). In a previous study of C4A genotypes in lupus, Kemp et al. detected a C4A deletion in -44% of unrelated white patients and -13% of normal controls (P < 0.05) (3) . It therefore appears that the frequency of C4A deletion may differ in healthy individuals from the population versus healthy members of SLE families (13 vs. 26%). Similarly, C4A deletion may occur less frequently in random cases of SLE (44%) than in patients from multicase families (56%). In this context, it is noteworthy that the frequency of hv3005 deletion among healthy individuals also increases from 8% in unrelated individuals to 21% in familial subjects. Why the disease-associated genotypes occur more frequently in healthy individuals from SLE families than in those from the general population is unknown at this point. Individuals included in the study were also assessed with respect to their inheritance of a putative disease-associated TCR a chain RFLP. The analysis failed to show any association of the disease with the 3-and 1.3-kb bands, previously suggested as representing the "SLE" allele (4) . The discrepancy between the current results and those previously reported with respect to this polymorphism may be due to ethnic difference in the populations analyzed in these two studies.
Extensive analyses of autoantibodies have revealed that certain autoantibodies are found regularly in the normal immune system, and that these autoantibodies are encoded by a restricted set of Vh genes which constitute the neonatal antibody repertoire (15) (16) (17) (18) (19) (20) (21) . These findings have led to a "network" hypothesis for autoimmune responses, wherein it is suggested that, during early ontogenesis and in the absence of exogenous antigens, autoreactive V genes are stimulated and selected by certain autoantigens to form the initial antibody repertoire (20, (22) (23) (24) . Once selected, the V genes interact with each other, to maintain the homeostasis of the antibody repertoire. In addition, some of these V genes serve as the first line of defense against infectious agents (25) (26) (27) . According to this hypothesis, the observed association of hv3005 deletion with SLE may be interpreted as implying that hv3005 represents an important autoreactive V gene and its homozygous deletion may result in generation of an aberrant B cell repertoire, with a consequent abnormal immune response to infection and predisposition of the host to development and/or perpetuation of autoimmune disorders. Alternatively, absence of hv3005 genes may exert its effect on immune response by virtue of altering immune complex clearance. Sequence comparisons reveal hv3005 to be highly homologous to the heavy chain of the SJ2 rheumatoid factor (28) and data from several groups suggest that rheumatoid factors enhance macrophage ingestion and clearance of immune complexes (29, 30) . Accordingly, deletion of hv3005-like genes may confer susceptibility to SLE by virtue of an effect on the production of rheumatoid factors. This paradigm may be analogous to that proposed for the association between homozygous C4A null alleles and SLE, an observation also ascribed to aberrations in the clearance and solublization of immune complexes (3) .
Recently, studies on the hv3005 and 1.9111-like Vh3 genes indicate this Vh locus to be complex and heterogeneous. As shown in Fig. 1 , these data suggest the existence of five hv3005 / 1.9111 haplotypes (6, 12, (31) (32) (33) (34) (35) (36) . Among these, the haplotype designated as type I contains the 3-33 and 3-30 genes, which differ from the hv3019b9 and 1.9111 genes comprising the type II haplotype by 4 and 1 bp, respectively (6, 32) . Type III haplotype is, in turn, distinguished from type II by an insertion of 5 Vh genes (including a duplicated copy of 1.9III, 4.34, 3d216/56Pl, 3d216d and DP65) (12, 32) ; 3d216 is highly homologous to hv3005 and is also deleted in individuals lacking the 9.4-kb band (6) . The type IV and V haplotypes contain the hv3005 and hv4005 genes which differ from 3d216 and 3d216d of type Ill by 2 and 22 bp, respectively (34) (31, 37, 38) . It is therefore possible that these hv3005-deleted haplotypes differ with regards to the extent to which they confer risk for SLE.
Although hv3005 deletion was associated with SLE in unrelated patients, the current study failed to detect an association between hv3005 deletion and SLE in familial cases. While the basis for this discrepancy is unclear, it is possible that in some individuals the critical function(s) of hv3005-like genes can be compensated by other autoreactive Vh genes. As such, the induction of SLE would require additional genetic hit(s) which deletes both copies of one or more of other physiologically important autoreactive Vh genes. By contrast, C4A is a single copy gene, and the product of the homologous C4B gene is less efficient in binding to immune complexes and in inhibiting immune precipitation. Thus, unlike hv3005, deletion of even only one copy of C4A gene may confer disease susceptibility. Taken together, the current data suggest that C4A deletion confers a strong genetic risk for SLE, while hv3005 deletion confers a weak risk for expression of this disease.
In evaluating these data, another possibility for consideration is that the influence of a weak disease susceptibility gene may be obscured by the effects of a strong disease susceptibility gene. In other words, the contribution of hv3005 to SLE susceptibility may be masked by the strong impact of C4A deletion and female sex. In this context, it is noteworthy that C4A deletions were detected in patients from 13/14 multicase SLE families, and in the single family not manifesting this defect (i.e., family 2), 3/3 patients showed hv3005 deletion, while the one healthy relative did not (Table I) . Similarly, hv3005 deletion, while not common in the familial cases of SLE, was detected in 2/5 (40%) unrelated male patients. These data raise the possibility that the influence of hv3005 deletion on disease predisposition is more easily detected in male than in female SLE patients and in SLE patients lacking C4A deletions.
In summary, the results of the current study on both familial and sporadic cases of SLE confirm the strong association between C4A deletion and SLE that has been reported in studies of unrelated patients. By contrast, while the findings confirm the previously detected association between hv3005 deletion and sporadic SLE, the data fail to support this association in SLE patients from multicase families. The results also suggest that C4A deletion and gender are major factors in susceptibility to SLE, while hv3005 deletion plays .a lesser role. Together, these data highlight the value of both family and population studies in identifying SLE-susceptibility genes. Analyses of multiplex families enable one to delineate the relative importance of candidate genes in SLE, and to determine how they may interact to enhance disease susceptibility.
